Annual Short Term Debt
$25.56 M
+$25.28 M+9092.81%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual short term debt is $25.56 million, with the most recent change of +$25.28 million (+9092.81%) on December 31, 2023.
- During the last 3 years, VIRX annual short term debt has risen by +$24.19 million (+1772.23%).
- VIRX annual short term debt is now at all-time high.
Performance
VIRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$16.91 M
-$1.91 M-10.14%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly short term debt is $16.91 million, with the most recent change of -$1.91 million (-10.14%) on September 30, 2024.
- Over the past year, VIRX quarterly short term debt has dropped by -$8.64 million (-33.83%).
- VIRX quarterly short term debt is now -33.84% below its all-time high of $25.56 million, reached on September 30, 2023.
Performance
VIRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
VIRX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9092.8% | -33.8% |
| 3 y3 years | +1772.2% | -33.8% |
| 5 y5 years | +1772.2% | -33.8% |
VIRX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +9092.8% | -33.8% | +5983.1% |
| 5 y | 5-year | at high | +9092.8% | -33.8% | +5983.1% |
| alltime | all time | at high | +9092.8% | -33.8% | +5983.1% |
Viracta Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.91 M(-10.1%) |
| Jun 2024 | - | $18.82 M(-0.2%) |
| Mar 2024 | - | $18.86 M(-26.2%) |
| Dec 2023 | $25.56 M(+9092.8%) | $25.56 M(-0.0%) |
| Sep 2023 | - | $25.56 M(+445.2%) |
| Jun 2023 | - | $4.69 M(+85.5%) |
| Mar 2023 | - | $2.53 M(+809.0%) |
| Dec 2022 | $278.00 K | $278.00 K(-26.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $378.00 K(-6.2%) |
| Jun 2022 | - | $403.00 K(+2.8%) |
| Mar 2022 | - | $392.00 K(+2.9%) |
| Dec 2021 | $381.00 K(-72.1%) | $381.00 K(+3.0%) |
| Sep 2021 | - | $370.00 K(-68.9%) |
| Jun 2021 | - | $1.19 M(+12.8%) |
| Mar 2021 | - | $1.06 M(-22.6%) |
| Dec 2020 | $1.36 M | $1.36 M |
FAQ
- What is Viracta Therapeutics annual short term debt?
- What is the all time high annual short term debt for Viracta Therapeutics?
- What is Viracta Therapeutics annual short term debt year-on-year change?
- What is Viracta Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly short term debt year-on-year change?
What is Viracta Therapeutics annual short term debt?
The current annual short term debt of VIRX is $25.56 M
What is the all time high annual short term debt for Viracta Therapeutics?
Viracta Therapeutics all-time high annual short term debt is $25.56 M
What is Viracta Therapeutics annual short term debt year-on-year change?
Over the past year, VIRX annual short term debt has changed by +$25.28 M (+9092.81%)
What is Viracta Therapeutics quarterly short term debt?
The current quarterly short term debt of VIRX is $16.91 M
What is the all time high quarterly short term debt for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly short term debt is $25.56 M
What is Viracta Therapeutics quarterly short term debt year-on-year change?
Over the past year, VIRX quarterly short term debt has changed by -$8.64 M (-33.83%)